Drug Receptor Assays: Quo Vadis?

Lowenstein JM Corrill EM . An improved method for measuring plasma and tissue concentrations of digitalis glycosides. J Lab Clin Med 1966; 67: 1048–52.

Bednarczyk B Soldin SJ Gasinska I D'Costa M Perrot L. Improved receptor assay for measuring digoxin activity. Clin Chem 1988; 34: 393–7.

Burnett GH Conklin RL . The enzymatic assay of plasma digoxin. J Lab Clin Med 1971; 78: 779–84.

Smith TW Butler VP Jr Haber E. Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay. N Engl J Med 1969; 281: 1212–6.

Redfors A. Plasma digoxin concentration—its relation to digoxin dosage and clinical effects in patients with atrial fibrillation. Br Heart J 1972; 34: 383–91.

Koch-Weser J Duhme DW Greenblatt DJ . Influence of serum digoxin concentration measurements on frequency of digitoxicity. Clin Pharmacol Ther 1974; 16: 284–7.

Duhme DW Greenblatt DJ Koch-Weser J. Reduction of digoxin toxicity associated with measurement of serum levels. A report from the Boston collaborative drug surveillance program. Ann Intern Med 1974; 80: 516–9.

Weintraub M. Interpretation of the serum digoxin concentration. Clin Pharmacokinet 1977; 2: 205–19.

Aronson JK . Clinical pharmacokinetics of digoxin. Clin Pharmacokinet 1980; 5: 137–49.

Smith TW Haber E. Clinical value of the radioimmunoassay of the digitalis glycosides. Pharmacol Rev 1973; 25: 219–28.

MacLeod SM Piafsky KM . Cardiac glycosides. In: Seeman P Sellers EM Roschlau WHE . (ed). Principles of Medical Pharmacology, 3rd edn. Toronto: University of Toronto Press, 1980; 303–10.

Soldin SJ Papanastasious-Diamandi A Heyes J Lingwood C Olley P. Are immunoassays for digoxin reliable? Clin Biochem 1984; 17: 317–20.

Gault MH Longerich L Dawe M Combined liquid chromatography/radioimmunoassay with improved specificity for serum digoxin. Clin Chem 1985; 31: 1272–7.

Stone JA Soldin SJ . Improved liquid chromatographic/immunoassay of digoxin in serum. Clin Chem 1988; 34: 2547–51.

Manchester EL Giesbrecht E Soldin SJ . Receptor radioligand system for measuring digoxin activity. Ther Drug Monit 1987; 9: 61–6.

Ballard PL Carter JP Graham BS A radioreceptor assay for evaluation of plasma glucocorticoid activity of natural and synthetic steroids in man. J Clin Endocrinol Metab 1975; 41: 290–304.

Soldin SJ Rifai N Palasynski EW The development of a radioreceptor assay to measure glucocorticoids. Ther Drug Monit (In press).

Jick H. What to Expect from Prednisone? Drug Therapy 1975; 5: 85–90.

Jusko WJ Rose JQ . Monitoring prednisone and prednisolone. Ther Drug Monit 1980; 2: 169–76.

Lipnick RN Morales A Getson PR Use of a radioreceptor assay in the assessment of Cushingoid features in patients with juvenile rheumatic diseases. Ther Drug Monit (In press).

Lader SR . A radioreceptor assay for neuroleptic drugs in plasma. J Immunoassay 1980; 1: 57–75.

Creese I Snyder SH . A simple and sensitive radioreceptor assay for antischizophrenic drugs in blood. Nature 1977; 270: 180–2.

Van Putten T. Guidelines to the use of plasma levels: A clinical perspective. J Clin Psychiatry, Monograph Series. 1984; 2: 28–32.

Rubin RT Forsman A Heykants J Serum haloperidol determinations in psychiatric patients: Comparison of methods and correlation with serum prolactin level. Arch Gen Psychiatry 1980; 37: 1069–74.

Van Putten T May PRA Marder SR Plasma levels of thiothixene by radioreceptor assay: Clinical usefulness. Psychopharmacology 1983: 79: 40–4.

Friedel RO . An overview of neuroleptic plasma levels: Pharmacokinetics and assay methodology. J Clin Psychiatry, Monograph Series 1984; 2: 8–12.

Copeland KR Yatscoff RW McKenna RM . Immunosuppressive activity of cyclosporine metabolites compared and characterized by mass spectrometry and nuclear magnetic resonance. Clin Chem 1990; 36: 225–9.

Yatscoff TW Rosano TG Bowers LD . Biological significance of cyclosporine metabolites. Clin Biochem 1991; 24: 23–36.

Donnelly JG Russell RL Palasynski EW Correlation of cyclosporine and metabolite binding to cyclophilin and a 50 KDa binding protein with in vitro immunosuppression: A preliminary report. Clin Biochem 1991; 24: 71–4.

Yatscoff RW Copeland KR Faraci CJ . Abbott TDx monoclonal antibody assay evaluated for measuring cyclosporine in whole blood. Clin Chem 1990; 36: 1969–73.

Hesse CJ Baan CC Daane R Comparison of four different cyclosporine immunoassays in heart and kidney transplant recipients. Ther Drug Monit 1990; 12: 547–53.

Palasynski EW Donnelly JG Soldin SJ . Purification and characterization of cyclosporine and FK-506 binding proteins from a human T-helper cell line. Clin Biochem 1991; 24: 63–70.

Handschumacher RE Harding MW Rice J Cyclophilin: A specific binding protein for cyclosporine A. Science 1984; 226: 544–7.

Sierkierka JJ Starmch MK Hung SHY FK-506, a potent novel immunosuppressive agent binds to a cyclosolic protein which is distinct from the cyclosporine A binding protein, cyclophilin. J Immunol 1989; 143: 1580–3.

Donnelly JG Soldin SJ . Cyclosporine, FK-506 and rapamycin interactions with a cytosolic binding protein. FASEB J 1991; 5: A730.

Donnelly JG Soldin SJ . A radioreceptor assay for the measurement of cyclosporine activity: A preliminary report. Ther Drug Monit 1989; 11: 696–700.

Russell RL Donnelly JG Palaszynski EW A preliminary study to evaluate an in vitro assay for determining patients whole blood immunosuppressive cyclosporine A and metabolite activity: Comparison with cytosolic binding assays using cyclophilin or a 50 kilodalton binding protein, and the Abbott TDx cyclosporine A parent, and parent and metabolites assays. Ther Drug Monit 1991; 13: 32–6.